Two independent human breast cancer gene expression datasets suggested that NUP210 mRNA expression was significantly associated with reduced overall survival (Fig. 2b, METABRIC) and DMFS (Fig. 2c, Km plotter)24 in estrogen receptor-positive (ER+) breast cancer patients. This evidence concerns the gene NUP210 and breast carcinoma.